Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (827)
- Medicine suspension (472)
- Complementary medicine cancellation (203)
- Medical device suspension (86)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (51)
- Medical device cancellation - certain devices within an entry (22)
- Registered medicine cancellation (12)
- Voluntary revocation at the request of the manufacturer (9)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- Medical device cancellation (1)
- Medical device cancellation – certain devices within an entry (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Results for
"[search-keyword]"
Search
1780 result(s) found, displaying 26 to 50
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe medicine is not eligible for listing (paragraph 30(1A)(a) of the Act).
It appears to the Secretary that the presentation of the goods in the case of listed goods is unacceptable (paragraph 30(2)(aa) of the Act). -
Cancellation or suspensionRegulatory action due to Voluntary revocation at the request of the manufacturer, effective 30/05/2024
-
Cancellation or suspensionRegulatory action due to Voluntary revocation at the request of the manufacturer, effective 07/05/2024
-
Cancellation or suspensionRegulatory action due to Voluntary revocation at the request of the manufacturer, effective 27/02/2024
-
Cancellation or suspensionRegulatory action due to Voluntary revocation at the request of the manufacturer, effective 07/05/2024
-
Cancellation or suspensionRegulatory action due to Voluntary revocation at the request of the manufacturer, effective 14/06/2024
-
Cancellation or suspensionWe have suspended Portable ventilator, electric/47083: BiPAP A40 EFL - AUX3000S19 from the ARTG under subsection s41GA(1)(b)
-
Cancellation or suspensionWe have suspended Portable ventilator, electric/47083: BiPAP A40 Pro - AUX3100S19 from the ARTG under subsection s41GA(1)(b)
-
Cancellation or suspensionWe have suspended Portable ventilator, electric/47083: OmniLab Advanced+ International w/Humidifer – 1111126 OmniLab Advanced+ International w/Heated Tube Humidifier - 1111127, Suspension from the ARTG under subsection s41GA(1)(b) from the ARTG under subsection s41GA(1)(b)
-
Cancellation or suspensionWe have suspended Positive airway pressure unit, bi-level/36990: BiPAP A30 Australia Silver Series – 1111145 BiPAP A30 Australia – 1076581 BiPAP A30 Australia, Core Package - 1076582 from the ARTG under subsection s41GA(1)(b)
-
Cancellation or suspensionWe have suspended Positive airway pressure unit, bi-level/36990: BiPAP A40, Australia - 1076583 BiPAP A40 Australia Silver Series - 1111171 from the ARTG under subsection s41GA(1)(b)
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024